Ruth Schmid leads the totally renewed Executive Board of the ETPN!

Ruth Schmid , VP Marketing at SINTEF, has been elected new chairperson of the ETP Nanomedicine Executive Board during the General Assembly held on June 17th 2019 on the fist day of the Nanomed Europe 2019 event (NME19) in Braga, Portugal. She will lead the platform with the support of a brilliant and entirely renewed team, with notably Agnès Pottier (Head of Discovery at Nanobiotix) and Raymond Schiffelers (Professor in Nanomedicine at UMC Utrecht) as vice chairpersons. Meet the new ETPN ExBo!

Discover the new ETPN ExBo

Join us at ETPN2020 on Oct. 14-16 in Heraklion

#ETPN2020 (www.etpn2020.eu) is the 15th annual event of the ETPN, and is coorganized this year again with IESL-FORTH. NEW DATES have been announced: October 14-16. Abstract submission open until the 14th of August. Early-bird registration fees available until 12th of June! ETPN2020 is a conference bringing together scientists, technology providers, entrepreneurs, industry and clinicians, all of them developing great medical applications of Nanotechnologies and emerging MedTech.

Know more

What is nanomedicine?

Nanomedicine is the application of nanotechnology to achieve innovation in healthcare. It uses the properties developed by a material at its nanometric scale 10-9 m which often differ in terms of physics, chemistry or biology from the same material at a bigger scale.

Moreover, the nanometric size is also the scale of many biological mechanisms in the human body allowing nanoparticles and nanomaterials to potentially cross natural barriers to access new sites of delivery and to interact with DNA or small proteins at different levels, in blood or within organs, tissues or cells.

Know more

ETPN strategic inputs

As a major pan-European industry-oriented initiative, the ETPN aims at strengthening Europe’s capabilities and competitiveness in the area of nanomedicine innovation. Since 2005 the ETPN published a number of strategic documents outlining the needs and roadmaps for nanomedicine research in Europe.

We have contributed to set up numerous European funded projects providing a first impression of the conditions for a suitable social and economic environment and the structural requirements for an efficient translation of R&D results into innovative nanomedicine.

Know more

ETPN support to innovation

Complementary to its strategic inputs as an ETP to shape and support public funding on the most promising areas of Nanomedicine, the ETPN has designed in 2014 unique technical infrastructures regrouped in a central instrument: the Nanomedicine Translation HUB.

These free of charge services support and accelerate the development of the best Nanomedicine projects from innovative design to clinical development.

Know more

Key reasons to become a member:

Meet new partners and end-users
Share your success stories
Benefit from unique advantages
Shape the future of Nanomedicine in europe
Promote and educate

Know more

Are you on the Nanomedicine map?

The NanoMed Map provides thorough insights into the nanomedicine community by showing all the actors of the ecosystem in Europe and beyond. It was initiated by NanoMed 2020, CSA project under FP7_Health.

See the map



Latest news

The NOBEL Project releases a compendium for testing, regulation, pricing and reimbursement of healthcare products.

Apr 1, 2020

The NOBEL Project, a Coordination and Support action coordinated by the ETPN, aiming to support a faster and easier translation to the market of all emerging medical technologies like Nanomedicine, has just released a compendium providing useful information for anyone...

ETPN position about Europe’s Beating Cancer Plan: get involved!

Mar 19, 2020

Dear ETPN members, dear colleagues, The European Commission has recently launched a consultation about Europe's Beating Cancer Plan. The ETPN is mobilized to play an active role in this action, since Nanomedicine is bringing a revolution in oncology. By reading this...